Home » Nitec: Lodotra Works in Late-Stage Arthritis Study
Nitec: Lodotra Works in Late-Stage Arthritis Study
Privately owned Swiss biotech firm Nitec said its Lodotra drug proved effective in a late-stage trial of patients with rheumatoid arthritis and it will use the data to apply for U.S. approval.
CNBC
CNBC
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May